Navigation Links
Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing

Japanese Pharmaceutical Company and Chinese Biotech Company join hands to form a new venture for production of drugs and clinical trials.

The Japanese company GNI merged with Chinese company Shanghai Genomics. // The wet lab facilities and validation would be done by Shanghai Genomics. China will be testing new lead compounds produced by GNI, such as new compounds for lung fibrosis and lung injury, such as damage from cancer radiotherapy, will be tested by china. China has about 300 million smokers and air pollution is high causing damaged lungs, which offers good atmosphere for testing of this new compound.

Ames Gross, President Pacific Bridge Medical is not happy with the mergers and is very much afraid of the potential problems such as copycats and piracy of the drugs. “Small companies that lack the resource to protect their IP in court need to be especially careful when thinking about sharing their inventions. Regulations and enforcement in places like China and India is improving, but it’s still possible to get burned.”

The merger would help intensify research in china in the field of medicine and drug discovery. This offer opens a new gate way of out-sourcing in the field of molecular biology, medicinal chemistry and pre-clinical testing to china. China offers low costs, access to large patients for clinical trials and rapidly growing market. “In the near future, Japan and China will be the world’s second and fifth largest pharmaceutical markets,” says Christopher Savoie, GNI’s chief executive.

(Source: Nature Biotechnoogy)
'"/>




Page: 1

Related medicine news :

1. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
2. Woman Tests Negative For Japanese Encephalitis: Health Minister
3. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
4. Schools set to offer Japanese language course
5. Girlie Needle And Thread help Japanese Men to De-Stress
6. Japanese Encephalitis Immunization Programme in India
7. Leprosy Cured People In India To Be Trained By Japanese Trust
8. Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive
9. Japanese Face High Risk Of Heart Attack And Stroke, Metabolic Syndrome to Blame
10. Japanese Scientists Develop Thought-Controlled Robotic Hands
11. Japanese Court Rules In Patients Favour Over Hepatitis C Scandal
Post Your Comments:
(Date:12/24/2014)... 2014 New studies reveal that women under ... related depression (March 6, 2014, JAMA Otolaryngology*). And although many ... (about 50 percent according to recent polls) facing hearing loss ... a person feels and relates to the world. People who ... also made by way of:, , self-confidence ...
(Date:12/24/2014)... Today, UWDress.com, the famous women’s dress supplier, ... and launched a site-wide wedding gown promotion. , ... in a more unexpected way, the collection should be a ... the global market, and they are available with custom service. ... at discounted prices, up to 75% off; most of them ...
(Date:12/24/2014)... 2014 Mike Billings , PT, ... Derek Fenwick, PT, MBA, GCS, Director of Professional ... from the passing of the Improving Medicare Post-Acute ... this taping of the Infinicast, the two leaders discuss ... Social Security Act to standardize post-acute assessment data for ...
(Date:12/24/2014)... The holidays can be a challenge for people who suffer ... drinks. "This is the season in which many people ... David Dodick, chair of the American Migraine Foundation, said in ... think through food and beverage choices, to help reduce the ... of neurology at the Mayo Clinic in Scottsdale, Ariz. , ...
(Date:12/24/2014)... Adults who experienced childhood abuse or neglect have ... study published online Dec. 24 in the journal ... long-lasting effects, like associated medical and psychological conditions ... director of behavioral medicine at Montefiore Headache Center ... news release. "When managing patients with migraine, ...
Breaking Medicine News(10 mins):Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Expert Offers Tips for Preventing Holiday Migraines 2Health News:Abuse in Childhood Tied to Migraines in Adulthood 2
... consumer,employer and labor organizations today announced a ... health insurers on principles,to guide how health ... to consumers., The "Patient Charter for ... today creates a national set of principles,to ...
... Turns Assets from Retirement Plans Into Guaranteed Income for ... ... NEW YORK, April 1, 2008 AXA Equitable Life,Insurance Company, ... variable annuity -- Crossings(SM): My Lifetime,IRA(SM), designed specifically as a ...
... disease , , TUESDAY, April 1 (HealthDay News) -- The weight-loss ... buildup of arterial plaque that,s connected with carrying too much ... evidence that the drug actually slowed disease progression, although it ... in arteries. , Acomplia also showed a high rate ...
... drug discovery and the pharmaceutical industry currently underway will ... to a top researcher at the National Institutes of ... drug research and development. , According to ... Center (NCGC), both industry and academia welcome more cooperation ...
... 2008) A catheter-mounted device that acts like a ... heart valve is not only reducing the abnormal backflow ... atrium, it is helping to shrink the enlarged, overworked ... surgery. These are the one-year findings in a small ...
... A new study has found that an x-ray dye ... prevent renal injury during percutaneous coronary intervention (PCI) in ... it made no difference in the need for dialysis ... the Contrast Media and Nephrotoxicity Following Coronary Revascularization by ...
Cached Medicine News:Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 4Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 2Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 3Health News:Business of drug development on verge of great change 2Health News:Catheter repair of mitral valve improves heart size, symptoms 2Health News:Catheter repair of mitral valve improves heart size, symptoms 3Health News:Iso-osmolar X-ray dye falters in PCI study 2Health News:Iso-osmolar X-ray dye falters in PCI study 3
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., the ... the proprietary Natural Killer (NK) cell-line platform, Neukoplast® ... Patrick Soon-Shiong , NantWorks founder, physician scientist ... agreement to purchase approximately $48 million of the ... the investment, he will be named Co-Chairman of ...
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
(Date:12/24/2014)... Dec. 23, 2014   Assurex Health, a ... to healthcare providers for behavioral health and chronic ... $30 million in equity financing from new and ... , President and Chief Executive Officer. ... development of Assurex Health,s GeneSight ® ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... in Patients Reduces,Severity of Adult Leukaemia , Copenhagen, ... company, announced today that SPC2996, the,Company's new RNA ... in an initial Phase I/II clinical study in ... were reported,this week at the 2007 Annual Meeting ...
... Shows Safety and Pharmacokinetics Similar to IV ... N.J., June 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated ... show the Company's lead anti-cancer drug,Genasense(R) (oblimersen ... subcutaneous (SC) injection, as well,as by brief ...
Cached Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
Batch Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 40 tests....
For use with catalog #0540....
Enzyme Immunoassay of D-Dimer by ELISA Method, 96 tests....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Medicine Products: